Fichero a descargar de la publicación mostrada - Sociedad ...

Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 59______________________________________________________________________________315. Raad II, Hachem RY, Hanna HA, et al. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter locksolutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded inbiofilm. Int J Antimicrob Agents 2008; 32:515-8.316. Sauer K, Steczko J, Ash SR. Effect of a solution containing citrate/Methylene Blue/parabens onStaphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions. J AntimicrobChemother 2009; 63:937-45.317. Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-relatedbloodstream infections in cancer patients. Int J Antimicrob Agents 2004; 24:491-5.318. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment ofbloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 2003;25:616-21.319. Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia oflong-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 2006; 160:1049-53.320. Broom J, Woods M, Allworth A, et al. Ethanol lock therapy to treat tunnelled central venous catheterassociatedblood stream infections: results from a prospective trial. Scand J Infect Dis 2008; 40:399-406.321. Wurzel CL, Halom K, Feldman JG, Rubin LG. Infection rates of Broviac-Hickman catheters and implantablevenous devices. Am J Dis Child 1988; 142:536-40.322. Shapiro ED, Wald ER, Nelson KA, Spiegelman KN. Broviac catheter-related bacteremia in oncology patients.Am J Dis Child 1982; 136:679-81.323. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients withmalignancies. Medicine (Baltimore) 1984; 63:189-200.324. Prince A, Heller B, Levy J, Heird WC. Management of fever in patients with central vein catheters. PediatrInfect Dis 1986; 5:20-4.325. King DR, Komer M, Hoffman J, et al. Broviac catheter sepsis: the natural history of an iatrogenic infection. JPediatr Surg 1985; 20:728-33.326. Flynn PM, Shenep JL, Stokes DC, Barrett FF. In situ management of confirmed central venous catheterrelatedbacteremia. Pediatr Infect Dis J 1987; 6:729-34.327. Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors ofcatheter removal in cancer patients. Infect Control Hosp Epidemiol 1995; 16:451-8.328. Reilly JJ Jr., Steed DL, Ritter PS. Indwelling venous access catheters in patients with acute leukemia. Cancer1984; 53:219-23.329. Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter foraccess to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148:871-5.330. Lazarus HM, Lowder JN, Herzig RH. Occlusion and infection in Broviac catheters during intensive cancertherapy. Cancer 1983; 52:2342-8.331. Capdevila JA, Segarra A, Planes AM, et al. Successful treatment of haemodialysis catheter-related sepsiswithout catheter removal. Nephrol Dial Transplant 1993; 8:231-4.332. Benoit JL, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheterinfections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21:1286-8.333. Douard MC, Arlet G, Leverger G, et al. Quantitative blood cultures for diagnosis and management of catheterrelatedsepsis in pediatric hematology and oncology patients. Intensive Care Med 1991; 17:30-5.